'Deck chairs on the Titanic'?: AMAG's CEO departure, drug dumps may not right the ship, analyst says

9th January 2020 Uncategorised 0

After forfeiting two board seats and undertaking a strategic review, AMAG Pharmaceuticals is saying goodbye to its CEO and two of its drugs. But with another med likely being pulled from the market, AMAG’s sudden decision to cut ties with its chief executive and rework its portfolio might not save a sinking ship, one analyst said. 

More: 'Deck chairs on the Titanic'?: AMAG's CEO departure, drug dumps may not right the ship, analyst says
Source: fierce